NL-OMON22870招募中不适用
Oral Fosfomycin versus Ciprofloxacin for Febrile Urinary Tract Infection in Men: a pilot study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- one
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Competent male patient aged 18 years or above
- •2. One or more symptom(s) suggestive of urinary tract infection (dysuria, frequency or
- •urgency; perineal or suprapubic pain; costo-vertebral tenderness or flank pain)
- •3. Fever (ear or rectal temp of 38.2 oC or higher, or axillary temp of 38 oC or higher), or
- •history of feeling feverish with shivering or rigors in the past 24 hours
- •4. Positive urine nitrate test and/or leucocyturia as depicted by positive leukocyte
- •esterase test or microscopy
- •5. Hospital admission for presumed FUTI and empirical intravenous antibiotic treatment
- •with beta-lactams
- •6. Positive urine (> 103 CFU/ml) culture and/or blood culture with E. coli susceptible to
- •fosfomycin, ciprofloxacin and the empirical intravenous beta-lactam treatment
- •7. Fullfilment of criteria for safe iv to oral switch (hemodynamic stability, ability to
- •consume oral antibiotics, no gastrointestinal problems which affect absorption)
排除标准
- •1. Known allergy to fosfomycin or ciprofloxacin
- •2. Patients with known polycystic kidney disease
- •3. Patients on permanent renal replacement therapy (hemodialysis or peritoneal
- •4. Patients with history of kidney transplantation
- •5. Patients with a permanent urinary catheter
- •6. Patients with chronic renal failure (eGFR < 30 ml/min/1.73m3)
- •7. Patients with renal abcess or pyonephrosis
- •8. Patients with chronic bacterial prostatitis (defined as recurrent UTI with the same
- •uropathogen and no other clarifying underlying urological disorder)
- •9. Patients with any diagnosed metastatic E. coli foci
- •10. Patients with a double-J or nephrostomy catheter
- •11. Concomitant systemic antibiotic treatment for another reason than FUTI
- •12. Residence outside the Netherlands
- •13. Inability to speak or read Dutch
- •Specific exclusion criteria for the FOS-MEN-pharm substudy is
- •1. Incontinency for urine, which results in the inability to properly get urine samples.
研究者
相似试验
进行中(未招募)
1 期
Oral Fosfomycin versus Ciprofloxacin for Febrile Urinary Tract Infection in Men: a pilot studyEUCTR2017-004963-11-NLHaga Teaching Hospital30
尚未招募
不适用
Oral Fosfomycin versus Ciprofloxacin for Febrile Urinary Tract Infection in Men: a pilot studyNL-OMON25027Haga Teaching Hospital30
招募中
3 期
Oral Fosfomycin versus Ciprofloxacin for Febrile Urinary Tract Infection in Men: a pilot studyurinary tract infectionNL-OMON55825HagaZiekenhuis30
已完成
不适用
Study comparing the efficacy of fosfomycin and ciprofloxacin antibiotics in the antibiotic prophylaxis of transrectal prostate biopsyprostatiteC01.915RBR-9tk9pwzniversidade Federal do Paraná - Campus Toledo
已完成
不适用
Comparison of Fosfomycin versus Ciprofloxacin in the initial management of uncomplicated UTICTRI/2017/09/009922niversity College of Medical Sciences120
